S. Kakolyris et al., HUMAN AP ENDONUCLEASE-1 (HAP1) PROTEIN EXPRESSION IN BREAST-CANCER CORRELATES WITH LYMPH-NODE STATUS AND ANGIOGENESIS, British Journal of Cancer, 77(7), 1998, pp. 1169-1173
Human AP endonuclease (HAP1) plays a major role in the repair of apuri
nic/apyrimidinic (AP) sites in cellular DNA. We used immunohistochemis
try to examine the expression of HAP1 in normal breast and in 102 prim
ary breast carcinomas. In normal breast epithelium, HAP1 had a uniform
ly nuclear localization. However, in lactating glandular epithelium, t
he expression of HAP1 was predominantly cytoplasmic. In carcinomas, bo
th nuclear and cytoplasmic (44%), cytoplasmic (28%) or nuclear stainin
g (24%) were observed. In four cases (4%), no HAP1 expression was dete
cted. All patterns of expression for HAP1 were demonstrated for ductal
carcinomas in situ (DCIS), although comedo-type DCIS were usually acc
ompanied by mostly cytoplasmic staining. Similarly, the HAP1 expressio
n in regions of invasive tumour necrosis was cytoplasmic. Pure nuclear
HAP1 expression was significantly correlated with low angiogenesis (P
= 0.007) and negative lymph node status (P = 0.001). In contrast, cas
es with cytoplasmic as well as nuclear staining were associated with p
oor prognostic factors, such as high angiogenesis (P = 0.03) and node
positivity (P = 0.03). The pure nuclear staining may be related to bet
ter differentiation, as in normal breast, and hence better prognostic
features, and cytoplasmic staining to a more metabolically active phen
otype with high protein synthesis, as in lactating breast.